<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01//EN"
                      "http://www.w3.org/TR/html4/strict.dtd">
<html lang="en">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=us-ascii">
<meta name="generator" content="hypermail 2.1.5, see http://www.hypermail.org/">
<title>Extropians: RE: telomerase cancer vaccine</title>
<meta name="Author" content="Damien Broderick (damienb@unimelb.edu.au)">
<meta name="Subject" content="RE: telomerase cancer vaccine">
<meta name="Date" content="2003-03-18">
<style type="text/css">
body {color: black; background: #ffffff}
h1.center {text-align: center}
div.center {text-align: center}
</style>
</head>
<body>
<h1>RE: telomerase cancer vaccine</h1>
<!-- received="Tue Mar 18 21:49:55 2003" -->
<!-- isoreceived="20030319044955" -->
<!-- sent="Wed, 19 Mar 2003 15:53:00 +1100" -->
<!-- isosent="20030319045300" -->
<!-- name="Damien Broderick" -->
<!-- email="damienb@unimelb.edu.au" -->
<!-- subject="RE: telomerase cancer vaccine" -->
<!-- id="3.0.6.32.20030319155300.00a3f4c0@truck.its.unimelb.edu.au" -->
<!-- charset="us-ascii" -->
<!-- inreplyto="7A2B25F8EB070940996FA543A70A217BBFDB63@adlexsv02.protech.c om.au" -->
<!-- expires="-1" -->
<p>
<strong>From:</strong> Damien Broderick (<a href="mailto:damienb@unimelb.edu.au?Subject=RE:%20telomerase%20cancer%20vaccine"><em>damienb@unimelb.edu.au</em></a>)<br>
<strong>Date:</strong> Tue Mar 18 2003 - 21:53:00 MST
</p>
<!-- next="start" -->
<li><strong>Next message:</strong> <a href="4640.html">Damien Broderick: "RE: telomerase cancer vaccine"</a>
<ul>
<li><strong>Previous message:</strong> <a href="4638.html">Ramez Naam: "RE: telomerase cancer vaccine"</a>
<li><strong>Maybe in reply to:</strong> <a href="4598.html">John K Clark: "telomerase cancer vaccine"</a>
<!-- nextthread="start" -->
<li><strong>Next in thread:</strong> <a href="4640.html">Damien Broderick: "RE: telomerase cancer vaccine"</a>
<!-- reply="end" -->
<li><strong>Messages sorted by:</strong> 
<a href="date.html#4639">[ date ]</a>
<a href="index.html#4639">[ thread ]</a>
<a href="subject.html#4639">[ subject ]</a>
<a href="author.html#4639">[ author ]</a>
<a href="attachment.html">[ attachment ]</a>
</ul>
<hr>
<!-- body="start" -->
<p>
At 12:10 PM 3/19/03 +1030, Emlyn wrote:
<br>
<p><em>&gt;What about if we find out down the
</em><br>
<em>&gt;track that there are really good reasons to sometimes turn telomerase on?
</em><br>
<p>There probably are unless you want to perish at the Hayflick limit, but you
<br>
can probably do without telomerase for a while, until the tumors are
<br>
extirpated, then switch it back on. The real problem is having it active in
<br>
all the trillions of somatic cells, because quite often by chance some of
<br>
those little buggers are going to accumulate all the necessary errors for a
<br>
cancer *except* active telomerase. It's a juggling act, up there in the
<br>
future. Of course for brains in vats like Emlyn corrosion might be a worse
<br>
hazard.
<br>
<p>Damien Broderick
<br>
<!-- body="end" -->
<hr>
<ul>
<!-- next="start" -->
<li><strong>Next message:</strong> <a href="4640.html">Damien Broderick: "RE: telomerase cancer vaccine"</a>
<li><strong>Previous message:</strong> <a href="4638.html">Ramez Naam: "RE: telomerase cancer vaccine"</a>
<li><strong>Maybe in reply to:</strong> <a href="4598.html">John K Clark: "telomerase cancer vaccine"</a>
<!-- nextthread="start" -->
<li><strong>Next in thread:</strong> <a href="4640.html">Damien Broderick: "RE: telomerase cancer vaccine"</a>
<!-- reply="end" -->
<li><strong>Messages sorted by:</strong> 
<a href="date.html#4639">[ date ]</a>
<a href="index.html#4639">[ thread ]</a>
<a href="subject.html#4639">[ subject ]</a>
<a href="author.html#4639">[ author ]</a>
<a href="attachment.html">[ attachment ]</a>
</ul>
<!-- trailer="footer" -->
<hr>
<p><small><em>
This archive was generated by <a href="http://www.hypermail.org/">hypermail 2.1.5</a> 
: Tue Mar 18 2003 - 21:59:25 MST
</em></small></p>
</body>
</html>
